The Role of Troponin in the Diagnosis and Treatment of Acute Pulmonary Embolism: Mechanisms of Elevation, Prognostic Evaluation, and Clinical Decision-Making.

acute pulmonary embolism diagnosis mechanisms prognostic evaluation troponin

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2024
Historique:
accepted: 27 08 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

Acute pulmonary embolism (APE) is a cardiovascular disease with severe consequences, wherein cardiac troponin (Tn) plays a pivotal role in diagnosis and treatment. This article reviews the various roles of Tn in managing APE. It looks at how Tn levels increase, their importance in predicting outcomes, and their use in making clinical decisions. Studies indicate that an elevation in Tn is primarily associated with right ventricular overload, ischemia, and necrosis, changes that directly reflect the extent of right ventricular dysfunction and myocardial injury. Elevated levels of Tn are significantly correlated with both short-term and long-term mortality risks in patients with APE, serving as crucial indicators for prognostic assessment and guiding therapeutic strategies. International guidelines recommend integrating Tn testing with clinical scoring and echocardiography to optimize treatment decisions in patients with APE. Despite the significant value of Tn determination in the management of APE, further research is needed to standardize its application. This paper emphasizes future research directions, including exploring the application of Tn in different patient subgroups with APE and its potential combined use with other biomarkers.

Identifiants

pubmed: 39328637
doi: 10.7759/cureus.67922
pmc: PMC11426936
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e67922

Informations de copyright

Copyright © 2024, Yang et al.

Déclaration de conflit d'intérêts

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Liu Yang (L)

Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, CHN.

Bin Li (B)

Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, CHN.

Huaigang Chen (H)

Department of Cardiology, Jiangxi Medical College, Nanchang University, Nanchang, CHN.
Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, CHN.

N Belfeki (N)

Department of Internal Medicine, Groupe Hospitalier Sud Île-de-France, Melun, FRA.

M Monchi (M)

Intensive Care Unit, Groupe Hospitalier Sud Île-de-France, Melun, FRA.

C Moini (C)

Department of Cardiology, Groupe Hospitalier Sud Île-de-France, Melun, FRA.

Classifications MeSH